Nisa Investment Advisors, LLC Revance Therapeutics, Inc. Transaction History

Nisa Investment Advisors, LLC

  • $24.1 Billion
  • Q4 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 18,730 shares of RVNC stock, worth $48,136. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,730
Previous 18,489 1.3%
Holding current value
$48,136
Previous $47,000 2.13%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025
BUY
N/A
241 Added 1.3%
18,730 $48,000
Q3 2024

Oct 24, 2024
SELL
$2.57 - $2.57 $1,084 - $1,084
-422 Reduced 2.23%
18,489 $47,000
Q2 2024

Jul 19, 2024
BUY
$2.34 - $4.73 $42,300 - $85,504
18,077 Added 2167.51%
18,911 $48,000
Q1 2024

May 01, 2024
BUY
$4.65 - $9.31 $576 - $1,154
124 Added 17.46%
834 $4,000
Q4 2023

Jan 25, 2024
BUY
$5.81 - $11.2 $87 - $168
15 Added 2.16%
710 $6,000
Q3 2023

Nov 02, 2023
SELL
$11.47 - $25.07 $286 - $626
-25 Reduced 3.47%
695 $7,000
Q2 2023

Aug 11, 2023
BUY
$24.7 - $37.61 $1,482 - $2,256
60 Added 9.09%
720 $18,000
Q1 2023

May 02, 2023
BUY
$18.36 - $35.27 $11,016 - $21,162
600 Added 1000.0%
660 $21,000
Q4 2022

Feb 02, 2023
BUY
$18.32 - $30.66 $146 - $245
8 Added 15.38%
60 $1,000
Q3 2022

Nov 07, 2022
BUY
$14.33 - $28.47 $745 - $1,480
52 New
52 $1,000
Q1 2022

Apr 29, 2022
SELL
$12.36 - $20.31 $9,270 - $15,232
-750 Closed
0 $0
Q4 2021

Feb 03, 2022
SELL
$12.46 - $27.87 $28,658 - $64,101
-2,300 Reduced 75.41%
750 $10,000
Q1 2021

Apr 26, 2021
BUY
$24.03 - $29.97 $45,657 - $56,943
1,900 Added 165.22%
3,050 $85,000
Q4 2020

Jan 25, 2021
SELL
$23.41 - $28.34 $26,921 - $32,591
-1,150 Reduced 50.0%
1,150 $33,000
Q3 2020

Oct 20, 2020
BUY
$23.23 - $34.3 $5,691 - $8,403
245 Added 11.92%
2,300 $58,000
Q2 2020

Jul 27, 2020
BUY
$12.6 - $26.55 $3,868 - $8,150
307 Added 17.56%
2,055 $50,000
Q4 2019

Jan 17, 2020
SELL
$11.66 - $20.15 $204,306 - $353,068
-17,522 Reduced 90.93%
1,748 $28,000
Q3 2019

Oct 17, 2019
BUY
$10.22 - $14.5 $196,939 - $279,415
19,270 New
19,270 $251,000

Others Institutions Holding RVNC

# of Institutions
232
Shares Held
83.2M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email